REQUEST A DEMO
Total
USD $0.00
Search more companies

Glenmark Pharmaceuticals Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Glenmark Pharmaceuticals Ltd. Profile Updated: February 14, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Glenmark Pharmaceuticals Limited engages in the manufacture and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company's products include Crofelemer, a Phase III clinical trial product for HIV-related diarrhoea; GRC 8200, which completed Phase IIb clinical trial for the treatment diabetes; GRC 4039 that completed Phase I clinical trial for the treatment of asthma, chronic obstructive pulmonary diseases, rheumatoid arthritis, and inflammatory disorders; and GRC 10693, which completed Phase I clinical trial for the treatment of neuropathic pain, osteoarthritis, and other inflammatory pain. The company was incorporated in 1977 and is based in Mumbai.

Legal Address
B/2, Mahalaxmi Chambers,, 22, Bhulabhai Desai Road,
Mumbai; Maharashtra; Postal Code: 400026

Contact Details: Purchase the Glenmark Pharmaceuticals Ltd. report to view the information.

Website: http://www.glenmarkpharma.com

Basic Information
Total Employees:
Purchase the Glenmark Pharmaceuticals Ltd. report to view the information.
Outstanding Shares:
Purchase the Glenmark Pharmaceuticals Ltd. report to view the information.
Registered Capital:
Purchase the Glenmark Pharmaceuticals Ltd. report to view the information.
Financial Auditors:
Purchase the Glenmark Pharmaceuticals Ltd. report to view the information.
Ratings:
Purchase the Glenmark Pharmaceuticals Ltd. report to view the information.
Incorporation Date:
1977
Key Executives
Purchase this report to view the information.
Chairman & Managing Director
Purchase this report to view the information.
Director - Corporate Affairs
Purchase this report to view the information.
Independent and Non Executive Director
Purchase this report to view the information.
Independent and Non Executive Director
Purchase this report to view the information.
Independent and Non Executive Director
Ownership Details
Purchase this report to view the information.
46.63%
Purchase this report to view the information.
25.84%
Purchase this report to view the information.
15.92%
Purchase this report to view the information.
5.88%
Purchase this report to view the information.
3.27%
Subsidiaries
Glenmark Arzheimittel Gmbh
100%
Glenmark Distributors SP Z o o
100%
Glenmark Dominican SA
100%
Company Performance
Financial values in the chart are available after Glenmark Pharmaceuticals Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
12.44%
Total operating revenue
12.44%
Operating profit (EBIT)
11.75%
EBITDA
11.32%
Net Profit (Loss) for the Period
-2.93%
Total assets
9.48%
Total equity
33.6%
Operating Profit Margin (ROS)
-0.09%
Net Profit Margin
-1.21%
Return on Equity (ROE)
-3.75%
Debt to Equity Ratio
-23.42%
Quick Ratio
0.04%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?